GlaxoSmithKline
GSK
$40.49
Share price
-0.91%
Change (1 day)
-0.42%
Change (1 year)
Categories
GlaxoSmithKline (GSK) Fails to deliver data
Key failure to deliver metrics for GlaxoSmithKline:
- Last SEC data release: 2025-05-30
- Last 15 days FTD volume: $10.01 M
- Last 3 months FTD volume: $97.99 M
- Last year FTD volume: $97.99 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for GlaxoSmithKline (GSK) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022
Volume in USD (price x number of shares), data since 2022GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $0.19 B | 33.07% |
| 2024 | $0.14 B | 395% |
| 2023 | $29.9 M | -43.98% |
| 2022 | $53.37 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 AstraZeneca AZN | $37.71 M | $0.14 B | 🇬🇧 UK |
 Pfizer PFE | $28.79 M | $0.35 B | 🇺🇸 USA |
 Merck MRK | $19.34 M | $0.18 B | 🇺🇸 USA |
 Novartis NVS | $41.23 M | $0.16 B | 🇨🇭 Switzerland |
 Sanofi SNY | $28.15 M | $43.66 M | 🇫🇷 France |
 Teva Pharmaceutical Industries TEVA | $12.09 M | $40.39 M | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.19 M | $31.53 M | 🇺🇸 USA |